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The human skeletal system is essential for support and 
movement of the body. An important structural material 
forming the skeletal system is an organic-inorganic 
composite called bone. This natural composite is 
composed of proteins in the form of collagen fibrils and 
macromolecules like proteoglycans that are all embedded 
in a well arrayed inorganic crystalline hydroxyapatite 
(HAP) matrix.1,2 It is this remarkable combination and 
distribution of constituent materials that gives bone its 
unique mechanical properties and its ability to withstand 
various mechanical and structural loads encountered 
during daily physical activity. HAP is a mineral 
composed of calcium and phosphate ions and has the 
general formula of [Ca10 (OH)2 (PO4)6]. The close 
chemical similarity between synthetic HAP and HAP 
naturally found in bone has led to an extensive research 
effort focused on using synthetic HAP as a viable bone 
replacement material in a number of clinical 
procedures.3,4 Unfortunately, due to synthetic HAP's low 
mechanical strength its use has been restricted to low 
load bearing applications. In a number of cases, its 
deficiencies have been improved by combining it with 
other materials. For example, materials such as high 
density polyethylene and polypropylene have been 
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successfully combined with synthetic HAP to improve its 
load bearing capabilities.5,6 Alternatively, other 
researchers have gone back to nature to look for a more 
effective way of producing biosynthetic materials and 
composites for potential tissue engineering applications. 
Seashells are naturally occurring ceramic composites that 
are dense, hard, and remarkably robust. The shell 
structure has a number of highly desirable mechanical 
properties that enable it to protect the soft body of the 
animal against environmental damage and predators. 
Shells are brittle or quasi-brittle materials composed of 
mineral components (~95%) and proteins (~5%). It is this 
compositional blend that gives a shell its high degree of 
stiffness and hardness. However, shell toughness and its 
ability to resist crack propagation that has attracted 
considerable interest.7,8 This interest stems from the 
observation that shell fracture toughness can be two to 
three orders of magnitude greater than the toughness of 
individual shell components.9 Another interesting feature 
is the much larger mechanical strain shells can withstand 
before failure compared to manmade ceramics.8,10     
Nacre is the inner iridescent layer found in Pinctada 
maxima (pearl oyster shell) and similar shells such as 
abalone. Nacre is composed of a crystalline calcium 
carbonate (CaCO3) mineral phase (aragonite) suspended 
in an organic matrix. The aragonite is in the form of 
polygon shaped tablets ranging in size from 5 to 15µm 
and 0.5 to 1µm in thickness that are stacked into a three 
dimensional brick wall-like structure. The wall-like 
structures can consist of columns or sheets depending on 
the species and typically forms 95% of the composite. 
Pearl oyster shells have a sheet-like structure. Recent 
atomic force microscopy studies have shown the 
individual tablets are suspended in an organic matrix of 
proteins and polysaccharides that makes up the remaining 
5% of the composite.11,12 Besides the highly advantageous 
mechanical properties, the nacre is biologically 
compatible with bone tissues.13,14 Because of the 
promising mechanical and biocompatibility properties, 
nacre is a prime candidate for potential tissue engineering 
applications. For example, recent animal in vivo studies 
by Berland et al have shown good cellular interaction 
between nacre implants and bone forming cells.15 From 
another perspective, Vecchio et al have been able to 
convert Strombus gigas (conch) and Tridacna gigas 
(Giant clam) shells to HAP while preserving their 
original dense columnar structure.16   
This article reports on the use of synthetically produced 
HAP and CaCO3 derived from waste oyster shells to form 
novel HAP/CaCO3 composites and HAP surface coatings 
on nacre. The first part of the article reports on the 
crystalline structure and morphology of synthesized 
nanometre scale HAP powders. The second part 
examines the use of shell derived CaCO3 that still retains 
properties of the shell to manufacture HAP/CaCO3 
composites. And thirdly, we report on the use of HAP 
surface coating on nacre substrates to improve 
biocompatibility and overcome poor mechanical 
properties inherent with pure HAP constructs.  
METHODS 
Materials 
All chemicals used in this work were supplied by Chem-
Supply (Australia) and all aqueous solutions were made 
using Milli-Q® water (18.3 M cm-1) produced by an 
ultrapure water system (Barnstead Ultrapure Water 
System D11931; Thermo Scientific, Dubuque, IA). 
Pinctada Maxima (pearl oyster) shells were supplied raw 
and were prepared as specified in the following 
procedure. 
Preparation of nanometer scale HAP powders 
A detailed description for producing HAP developed by 
the authors can be found in the literature.17,18 For 
completeness, a brief procedural description is outlined as 
follows.  
 
Figure 1: Schematic of synthesis process for 
producing HAP and HAP/CaCO3 composites. 
The procedure begins by first adding a 40mL solution of 
0.32 M calcium nitrate tetra-hydrate into a small glass 
beaker and then adjusting the solution pH to 9.0 using 
approximately 2.5ml of ammonium hydroxide. The 
solution is then sonicated using a Hielscher Ultrasound 
Processor UP50H set at 50 W and maximum amplitude 
for 1 h. During sonication, 60 mL of 0.19 M potassium 
di-hydrogen phosphate solution was slowly added while 
the solution pH was maintained at 9.0 and the 
Calcium/Phosphate [Ca/P] ratio was maintained at 1.67. 
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At the end of the sonication period, the solution was 
centrifuged (15,000 g) for 20 minutes at room 
temperature to produce a precipitate. The precipitate was 
collected, washed and centrifuged for a further 10 
minutes before being placed into a ceramic boat ready for 
heat treatment. The heat treatment consisted of placing a 
sample loaded ceramic boat into an electric tube furnace. 
The reaction temperatures used were either 300°C or 
400°C and the reaction time period was 2 hours for 
temperatures. After thermal treatment, the agglomerated 
samples were milled to form an ultrafine HAP powder. A 
schematic of the synthesis process is presented in (Figure 
1). 
Preparation of HAP based calcium carbonate composite 
powders  
CaCO3 was derived from Pinctada maxima (pearl oyster) 
shells. The shells were first washed and scrubbed to 
removal all traces of organic matter. This was followed 
by giving the shells a final wash down using Milli-Q® 
water and then allowing them to air dry before being 
stored for the next stage of process. Shell material was 
used in two forms. In the first form shells underwent 
milling to produce CaCO3 powders of varying grades. A 
metallurgical ring crusher was used to crush and grind the 
shells into a powder. After grinding, a Roto-Tap was used 
for 30 minute to sieve the powder. Sieving produce a 
variety of powder grades ranging from 38 to 850 
micrometres as seen in (Figure 2). In the second form 
shells were cut into 1 cm2 test substrates. 
 
Figure 2: (a) Pinctada maxima (pearl oyster) shells 
and (b) Various grades produced after sieving CaCO3 
powder (38 to 850 micrometers). 
Preparation of the HAP/CaCO3 composites started by 
selecting the appropriate CaCO3 grade and then weighing 
out the required mass. In this case the mass percentages 
of CaCO3 selected were 5% and 10%, with the remaining 
mass balance made up of HAP powder. However, before 
being incorporated into the HAP synthesis process the 
CaCO3 powders were bleached for 30 minutes. The 
bleached CaCO3 was then added to the HAP processing 
procedure to produce the required blend as seen in 
(Figure 1). Visual inspection during processing and after 
heat treatment revealed a noticeable difference between 
pure HAP powders, pure CaCO3 powders and the 
respective HAP/CaCO3 powder blends. However, 
differences between the 5% and 10% CaCO3 blends were 
much harder to distinguish and could only be 
differentiated under electron microscopy. (Figure 3) 
presents a representative image of a 10% CaCO3 blend. 
 
Figure 3: Representative electron microscopy image 
of HAP/CaCO3 powder blend. 
Preparation of shell substrates  
The second part of the study used the shell as a substrate 
for the deposition of a HAP coating. The substrates were 
prepared by first pre-washing and cleaning the raw shells. 
After cleaning the shells were placed in a clean bench 
vice and cut into 1 cm2 test substrates using a standard 
hacksaw (32 teeth per 25mm). Substrates were then 
washed in running water in the lab sink to remove all 
cutting debris. In the next stage of cleaning samples were 
placed into a 250ml beaker of Milli-Q® water then 
exposed to ultrasonic irradiation for 10 minutes to 
remove any loose particles that may have been embedded 
in the samples during the cutting stage. After the first 
irradiation, the Milli-Q® water was changed and the 
process repeated. In total, the samples were treated three 
times before being air dried and stored ready for surface 
treatment. 
Substrate surface treatments and coatings  
A specific surface pre-treatment was applied to each 
respective substrate prior to coating. This was done to 
gauge the effectiveness of each surface pre-treatment in 
promoting coating attachment. Five pre-treatment 
procedures and an untreated substrate (control) were 
investigated and details of each pre-treatment are 
presented in (Table 1). The surface coating procedure 
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consisted of using a spatula to evenly spread a layer of 
HAP powder over the surface of sample types 2 to 6, 
sample 1 being the unloaded control sample. After 
coating, all samples were placed into ceramic furnace 
boats and then individually placed into a pre-heated 
furnace set to 400°C. Samples remained in the furnace for 
2 hours to calcify the coating in the presence of 
atmospheric air. After 2 hours of thermal treatment, the 
ceramic boats were removed from the furnace and 
allowed to cool down to room temperature in air.  
 
Table 1: Substrate surface pre-treatments used prior to coating application. 
Substrate type Surface treatment Description 





Sample is placed into a 500ml beaker containing 200ml of Milli-Q® water 
and 10 ml of 35% HCL. Solution pH was measured and found to be 1. The 
sample remains in the solution for 3 minutes. It is then removed and washed 






Sample is placed into a 500ml beaker containing 200ml of household bleach. 
(45g/l of sodium hypo chlorate). The sample remains in the solution for 30 
minutes. It is then removed and washed with Milli-Q® water and then air 
dried.  
4 Boiling (B) 
Sample is placed into a 500ml beaker containing 200ml of Milli-Q® water 
and boiled for 10 minutes. It was then removed and washed with Milli-Q® 




Sample is roughened using silicon carbide sand paper (180p). 15 lateral 
movements followed by 15 vertical movements. The sample was then placed 
into a 500ml beaker containing 200ml of Milli-Q® water and exposed to 5 
minutes of ultrasonic irradiation to remove any loose particles and 
contamination from the sand paper. The sample was then air dried. 
6 Mechanical (S) 
Sample is placed into a bench vice. The sample is scored by 20 lateral 
movements (both directions) by a surgical scalpel. The sample was then 
placed into a 500ml beaker containing 200ml of Milli-Q® water and exposed 
to 5 minutes of ultrasonic irradiation to remove any loose particles. The 
sample was then air dried.  
 
Advanced characterization 
Powder X-ray diffraction (XRD) spectroscopy was used 
to identify the crystalline size and phases present in 
synthesized HAP powders. Spectroscopy data was 
recorded at room temperature, using a Siemens D500 
series diffractometer [Cu Kα=1.5406Å radiation source] 
operating at 40kV and 30mA. The diffraction patterns 
were collected over a 2θ range of 20° to 60° with an 
incremental step size of 0.04° using flat plane geometry 
with a 2 second acquisition time for each scan. The 
crystalline size of the particles was calculated using the 
Debye-Scherrer equation (Equation 1) from the 
respective spectroscopy patterns. Field emission scanning 
electron microscopy (FESEM) was also used to study 
size, shape and morphological features of the various 
powders. All micrographs were taken using a high 
resolution FESEM [Zeiss 1555 VP-FESEM] at 3kV with 
a 30µm aperture operating under a pressure of 1.333x10-
10 mbar. Samples were mounted on individual substrate 
holders using carbon adhesive tape before being sputter 
coated with a 2nm layer of gold to prevent charge build 
up using a Cressington 208HR High Resolution Sputter 
coater. 
RESULTS 
XRD spectroscopy analysis of synthesised HAP powders 
XRD spectroscopy was used to identify the crystalline 
size of the synthesised nanometre scale HAP powders. A 
representative XRD pattern of a thermally treated HAP 
powder (400ºC for 2 h) is presented in (Figure 4). The 
pattern shows the main (h k l) indices found in the 
sample, namely (002), (211), (112), (300), (202), (310), 
(222), (213) and (004). These indices match the known 
phases present in pure HAP and are consistent with the 
phases listed in the ICDD database. The crystalline size, 
t(hkl), of each sample was calculated from the respective 
XRD patterns using the Debye-Scherrer equation 
below.19-20 
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where, λ is the wavelength of the monochromatic X-ray 
beam, B is the full width at half maximum (FWHM) of 
the peak at the maximum intensity, θ(hkl) is the peak 
diffraction angle that satisfies Bragg’s law for the (h k l) 
plane and t(hkl) is the crystallite size. The crystallite size of 
each sample was calculated from the (002) reflection 
peak. HAP samples thermally treated at 400ºC gave a 
mean particle size of 30 nm.  
 
Figure 4: Representative XRD pattern of a HAP 
powder after thermal treatment. 
FESEM analysis of pure and blended powders  
FESEM was used to study particle size and morphology 
of the pure powders and blended powders. Representative 
micrographs of manufactured powders are presented in 
(Figure 5). (Figure 5b) reveals a spherical/granular 
particle morphology that is highly agglomerated and is 
typical of the synthesised HAP powder samples. Also 
present in (Figure 5b) are three 50 nm diameter circles 
placed randomly to highlight the spherical/granular 
morphology. This morphology is similar to particle 
morphologies previously reported in the literature.21-22  
The raw CaCO3 powder was sifted through a 38 micron 
sieve to produce a relatively homogeneous powder 
consisting of thin plates and finer granular shaped 
particles ranging in size from 20 to 100nm as seen in 
(Figure 5a). A representative micrograph of a 
HAP/CaCO3 composite (5%) is presented in (Figure 5c) 
and reveals the presence of granular shaped particles with 
pronounced edges that appear to be moderately packed 
and range in size from 50 to 100nm. This is in stark 
contrast to the smooth and spherical HAP particle 
morphologies seen in (Figure 5b). (Figure 5d) presents a 
representative micrograph of a HAP/CaCO3 (10%) and 
also reveals the presence of tightly packed granular 
particles. The particles range in size from 50 to 100nm 
and have similar morphology to particles seen in the 
HAP/CaCO3 (5%) composite. Analysis of FESEM 
micrographs taken of composite samples has confirmed 
the influence of CaCO3 on particle morphology during the 
synthesis of the HAP composites. Furthermore, 
investigation of the various surface pre-treatments and 
coatings revealed varying degrees of effectiveness in 
coating the substrates and these results are evaluated in 
the following discussion section.  
 
Figure 5: (a) Milled CaCO3 powder sifted through a 
38 micron sieve; (b) Pure ultrafine HAP powder; (c) 
HAP/CaCO3 composite (5% CaCO3 and particle sizes 
less than 38 micron) and (d) HAP/CaCO3 composite 
(10% CaCO3 particle graded between                               
38 and 75 microns). 
DISCUSSION 
The HAP powders synthesised in the present work had 
structural and chemical properties similar to those 
reported in the literature.23,24 XRD analysis also 
confirmed the crystallinity of the sample powders were 
similar to those reported by other researchers and in 
particular conformed well to previous crystal structure 
modelling carried out by the authors.25,26 The 
spherical/granular morphology of the nanometre scale 
HAP particles was also consistent with those produced by 
similar ultrasound based synthesis techniques.27,28 The 
manufactured HAP powders also displayed similar 
physiochemical properties to those manufactured using 
other techniques such as wet precipitation and spray 
pyrolysis.29,30 In terms of HAP based coating techniques, 
the present work used a straightforward treatment 
technique that did not require complex and expensive 
application equipment or complex processes such as ion 
beam surface structuring, plasma-vapour and surface 
patterning and texturing.31 HAP deposition and coating 
attachment on the various substrate types used in the 
present work revealed some interesting surface features 
after thermal treatment. After thermal treatment in a 
conventional tube furnace each substrate showed some 
degree of lamellae bubbling. Inspection of the Type 1 
(control-no surface pre-treatments) substrate revealed 
a b 
c d 
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signs of surface bubbling, but still retained its pearlescent 
lustre. The remaining 5 substrate types all exhibited a dull 
white coating that indicated HAP had indeed adhered to 
the respective surfaces. The appearance of this type of 
deposition is consistent with similar HAP deposition 
studies.32,33 The Type 2 (HCl) substrate also showed signs 
of minor delaminating, but the majority of the HAP 
coating remained attached to the surface. While the Type 
3 (SH) substrate that had undergone a bleaching pre-
treatment showed the most significant change. Its surface 
had a very distinctive white appearance that was much 
thicker and denser when compared to the other substrate 
types. The Type 4 (B) substrate which had undergone a 
boiling pre-treatment showed significant lamellae 
delaminating. The substrate was also found to be very 
brittle after the thermal treatment. Overall, the Type 4 
substrate displayed poor mechanical properties and 
inferior surface properties compared to the other substrate 
types. Studies by other researchers have shown the 
importance of good mechanical compliance for ceramic 
coating to be effectively used in any tissue engineering 
application.34 The present work has shown the Type 4 
substrate is unsuitable for tissue engineering applications. 
On the other hand, both Type 5 (A) and Type 6 (S) 
substrates revealed significant amounts of HAP was 
trapped within the rough surface features created by the 
respective surface texturing treatments. Surface texturing 
used in Type 6 trapped the largest amounts of HAP and 
significantly contributed to coating integrity. Generally, 
both surface texturing techniques were found to be 
beneficial in promoting surface fixation of the coatings. 
Studies have shown that texturing of implant surfaces can 
improve protein adsorption and promote positive cellular 
responses.35 However, in the present case further cell-line 
studies are needed to confirm the biocompatibility and 
suitability of the substrates. 
FESEM surface studies carried out on the various 
substrate types also revealed some interesting surface 
features. Interestingly, the Type 1 (control) substrate was 
found to have traces of HAP on its surface, even though 
there was no HAP coating was applied to its surface. The 
presence of individual HAP particles was found to be the 
result of ongoing calcification processes occurring within 
the furnace environment as seen in (Figure 6a). During 
thermal treatment, both water and NH4 evaporating from 
surrounding substrates tended to deposit on everything 
within the furnace, including the Type 1 substrate. 
However, the other substrate types did not show this type 
of surface feature. Examining the FESEM images of the 
Type 2 (HCI) substrate revealed a thick surface covering, 
unfortunately the coating was not uniformly distributed 
over the entire surface. Numerous uncoated regions could 
be seen over the substrates surface, which revealed the 
underlying lamellae structure as seen (Figure 6b). The 
poor surface covering makes the Type 2 an inferior 
substrate and tends to reduce the coating functionality 
and biological response ability to various cell-line.36 Type 
3 (SH) substrates were evenly covered with a thick and 
dense HAP surface coating and unlike the Type 2 
substrate had far fewer exposed underlining lamellae 
regions. The deposited HAP produced a superior coating 
on the pre-treated (bleached) surfaces of Type 3 
substrates than those of the acid pre-treated (HCI) 
surfaces of the Type 2 substrates as seen in (Figure 6c) 
and (Figure 6d). In both cases, the mean HAP particle 
size found on both substrate types was estimated to be 
around 500 nm. In the case of Type 5 and Type 6 
substrates, the surface coatings were not thick or 
uniformly distributed. Instead the HAP tended to 
accumulate within and around the roughened (textured) 
surface features. This type of deposition resulted in poor 
surface coverage and produced large areas of uncoated 
substrate. However, further studies are needed to fully 
investigate the effects of surface texturing, and in 
particular the effects of surface texturing before 
chemically treating substrates with bleach as in the case 
of Type 3 substrates. The pre-treated (bleaching) Type 3 
(SH) substrates were found to produce a superior HAP 
surface coating compared to other substrate types tested 
in this study. Future studies are planned to investigate the 
wear properties and load bearing capacity of the Type 3 
(SH) substrates. In addition, in vitro studies are also 
planned to investigate the biocompatibility of the 
substrates towards a number of bone cell-lines. 
 
Figure 6 FESEM analysis of various substrate 
surfaces: (a) Substrate Type 1 (Control) showing the 
deposition of HAP particles during the calcination 
process; (b) Type 2 (HCl) showing minor 
delaminating of the thin HAP coating;                                    
(c) Type 2 (HCl) enlarged view of coating with 
underlying lamellae exposed, and (d) Type 3 (SH) 
substrate showing an evenly distributed thick coating 
over the entire substrate surface with far fewer 
exposed lamellae regions. 
a b 
c d 
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CONCLUSION 
HAP is a calcium phosphate that is considered to be a 
viable replacement for bone material in a number of low-
load bearing tissue engineering applications. While the 
nacre layer found inside the Pinctada maxima (pearl 
oyster) shell is hard, stiff, and extremely tough. The 
present study has shown that a nanometer scale HAP 
powder (mean particle size of 30 nm) can be combined 
with sieved powders derived from Pinctada maxima 
(CaCO3) to produce a composite powder. During 
synthesis, the addition of sieved powders were found to 
influence particle size and morphology of composite 
powders. The tough nacre was used as a substrate and a 
number of surface pre-treatments were investigated 
before the substrates were coated with HAP. The results 
of the investigation revealed a substrate pre-treated with 
sodium hypo chlorate (Type 3) before HAP deposition 
produced the superior coating. The surface coating was 
thick, dense and evenly distributed. However, further 
studies are needed to investigate wear properties and load 
bearing capacities of the Type 3 substrate. Future in vitro 
studies are planned to determine the biocompatibility of 
the substrates towards a number of bone cell lines.  
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